Neurofibromatosis Type 1: Molecular and Cellular Biology

作者: D.H. Viskochil , D.A. Stevenson

DOI: 10.1016/B978-008045046-9.00596-9

关键词:

摘要: Neurofibromatosis type 1 (NF1) is a common autosomal dominant condition frequently described as neurocutaneous disorder. The prototypical findings of NF1 include cafe-au-lait macules, neurofibromas, axillary or groin frecklings, optic pathway tumors, Lisch nodules (benign hamartomas the iris), and unique dysplastic skeletal (long bone bowing/pseudarthrosis and/or sphenoid wing dysplasia). This genetic has high degree clinical variability, with affected members same family sometimes displaying significantly different manifestations. It is, however, fully penetrant in adults. affects individuals without predilection to ethnicity gender. gene was cloned by mapping approach, its DNA sequence encodes peptide, neurofibromin, that homology p21Ras GTPase-activating proteins. role neurofibromin plays Ras signal transduction suggests mechanism for pathophysiology approaches development rational therapy this

参考文章(10)
David Viskochil, Neurofibromatosis Type 1 Management of Genetic Syndromes. pp. 549- 568 ,(2005) , 10.1002/9780470893159.CH37
S. M. Huson, R. A. C. Hughes, The Neurofibromatoses : a pathogenetic and clinical overview Chapman & Hall Medical. ,(1994)
James Smirniotopoulos, Vincent M. Riccardi, Neurofibromatosis : phenotype, natural history, and pathogenesis Journal of Neuropathology and Experimental Neurology. ,vol. 51, pp. 658- 658 ,(1992) , 10.1097/00005072-199211000-00009
Ludwine M. Messiaen, Tom Callens, Geert Mortier, Diane Beysen, Ina Vandenbroucke, Nadine Van Roy, Frank Speleman, Anne De Paepe, Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Human Mutation. ,vol. 15, pp. 541- 555 ,(2000) , 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N
Vincent M. Riccardi, Von Recklinghausen neurofibromatosis. The New England Journal of Medicine. ,vol. 305, pp. 1617- 1627 ,(1981) , 10.1056/NEJM198112313052704
Helen Young, Shelley Hyman, Kathryn North, Neurofibromatosis 1: clinical review and exceptions to the rules. Journal of Child Neurology. ,vol. 17, pp. 613- 621 ,(2002) , 10.1177/088307380201700812
André Bernards, Neurofibromatosis type 1 and Ras-mediated signaling: filling in the GAPs Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. ,vol. 1242, pp. 43- 59 ,(1995) , 10.1016/0304-419X(95)00003-X
David H. Gutmann, The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2 JAMA: The Journal of the American Medical Association. ,vol. 278, pp. 51- 57 ,(1997) , 10.1001/JAMA.1997.03550010065042
D Viskochil, R White, R Cawthon, The Neurofibromatosis Type 1 Gene Annual Review of Neuroscience. ,vol. 16, pp. 183- 205 ,(1993) , 10.1146/ANNUREV.NE.16.030193.001151
J. M. Friedman, Patricia H. Birch, Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients American Journal of Medical Genetics. ,vol. 70, pp. 138- 143 ,(1997) , 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U